Connecticut 2013 Regular Session

Connecticut Senate Bill SB00465

Introduced
1/23/13  
Introduced
1/23/13  
Refer
1/23/13  
Refer
1/23/13  
Refer
2/8/13  
Refer
2/8/13  
Report Pass
3/11/13  
Report Pass
3/11/13  
Refer
3/18/13  
Refer
3/18/13  
Report Pass
3/25/13  
Report Pass
3/25/13  
Refer
4/24/13  
Refer
4/24/13  
Report Pass
4/30/13  
Report Pass
5/1/13  
Refer
5/8/13  
Report Pass
5/14/13  
Report Pass
5/14/13  
Engrossed
5/23/13  
Report Pass
5/24/13  
Report Pass
5/24/13  
Chaptered
6/17/13  
Enrolled
6/19/13  
Enrolled
6/19/13  
Passed
7/2/13  

Caption

An Act Concerning Newborn Screening For Adrenoleukodystrophy.

Impact

The modifications outlined in SB 465 will directly revise state health statutes related to newborn screening. By adding ALD to the screening process for newborns, this legislation aims to provide critical early interventions that could significantly improve health outcomes for affected children. The Department of Public Health is tasked with managing the new screening program and ensuring that healthcare institutions comply with the updated regulations, which is a shift towards more comprehensive genetic health monitoring in infants.

Summary

Senate Bill 465, also referred to as the Act Concerning Newborn Screening for Adrenoleukodystrophy, was introduced to enhance screening protocols for newborns in Connecticut. The bill mandates that specific testing for adrenoleukodystrophy (ALD) be administered to all newborns once a reliable test method is validated and approved by federal authorities. This amendment is aimed at improving early detection of this genetic disorder, which can lead to severe health issues if not diagnosed promptly.

Sentiment

The general sentiment surrounding SB 465 appears to be positive, especially among healthcare professionals and advocates for children's health. Supporters argue that timely screening can lead to better management of ALD, reducing long-term health complications. However, there are potential concerns from specific groups about the implications of mandatory testing, particularly regarding parental rights and the potential for overreach into personal health decisions.

Contention

While the bill enjoys broad support, there are notable points of contention primarily focused on parental consent and the potential for mandated health interventions. Critics may voice concerns regarding how such mandates could infringe on personal freedoms and whether adequate information about the tests and their implications are provided to parents. The successful implementation of the bill hinges on balance between public health benefits and respect for individual choices.

Companion Bills

No companion bills found.

Previously Filed As

CT HB05321

An Act Requiring Newborn Screening For Duchenne Muscular Dystrophy.

CT SB00001

An Act Concerning The Health And Safety Of Connecticut Residents.

CT HB05322

An Act Concerning The Distribution Of Educational Materials Regarding Intimate Partner Violence Toward Pregnant And Postpartum Patients.

CT SB00440

An Act Concerning Certificates Of Need.

CT HB05320

An Act Concerning Hospital Financial Assistance.

CT SB00133

An Act Concerning Regulation Of Prescription Drugs And Related Professions.

CT SB00349

An Act Concerning Dyslexia Screening Of Individuals Who Are Incarcerated.

CT SB00212

An Act Concerning The Revisor's Technical Corrections To The General Statutes.

CT HB05488

An Act Concerning Various Revisions To The Public Health Statutes.

CT SB00369

An Act Concerning Home Care Worker Safety.

Similar Bills

No similar bills found.